Literature DB >> 17846059

Multiple myeloma: causes and consequences of delay in diagnosis.

C C Kariyawasan1, D A Hughes, M M Jayatillake, A B Mehta.   

Abstract

BACKGROUND: Myeloma is a serious and usually fatal haematological malignancy with reported mortality of 10-20% within the first 2 months of presentation. Symptoms are non-specific, and patients thus present to a range of medical practitioners. AIM: To analyse the causes and consequences of a delay in diagnosis of myeloma.
DESIGN: Retrospective case review.
METHODS: The number and type of disease-related complications present at diagnosis of 92 patients with myeloma were categorized according to the medical practitioner to whom the patient initially presented, the time before diagnosis and the status of the patient at study end in 2006. Overall and disease-free survival were analysed.
RESULTS: Duration of symptoms >6 months prior to diagnosis was seen in 40% of the patients, of whom >50% had initially consulted a general practitioner. The most common presenting symptom (67%) was bone pain. The most common complications present at diagnosis were anaemia (54%), bone disease (45%) and renal failure (36%), with the highest frequency of complications in the group experiencing symptoms for >6 months. All patients in this group had two or more complications, while 40% in the group with symptoms for <3 months had no complications. A prolonged time to diagnosis had a significant effect on disease-free survival from both onset of first symptoms (p = 0.043) and from diagnosis (p = 0.003), but not on overall survival. DISCUSSION: A prolonged delay before diagnosis is associated with a significant impact on the clinical course of multiple myeloma. There is a need to raise awareness of the presentation of this condition, especially among general practitioners.

Entities:  

Mesh:

Year:  2007        PMID: 17846059     DOI: 10.1093/qjmed/hcm077

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  42 in total

1.  Statin use and risk of multiple myeloma: An analysis from the cancer research network.

Authors:  Mara M Epstein; George Divine; Chun R Chao; Karen E Wells; Heather Spencer Feigelson; Delia Scholes; Douglas Roblin; Marianne Ulcickas Yood; Lawrence S Engel; Andrew Taylor; Joan Fortuny; Laurel A Habel; Christine C Johnson
Journal:  Int J Cancer       Date:  2017-05-15       Impact factor: 7.396

Review 2.  The Diagnosis and Treatment of Multiple Myeloma.

Authors:  Christian Gerecke; Stephan Fuhrmann; Susanne Strifler; Martin Schmidt-Hieber; Hermann Einsele; Stefan Knop
Journal:  Dtsch Arztebl Int       Date:  2016-07-11       Impact factor: 5.594

3.  Change in blood test results prior to diagnosis in multiple myeloma.

Authors:  Catherine Atkin; Elizabeth Sapey; Alex Richter
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

4.  Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue.

Authors:  Jiangtao Shen; Xinru Du; Lingxiu Zhao; Hui Luo; Ziyu Xu
Journal:  Oncol Lett       Date:  2018-04-24       Impact factor: 2.967

5.  Streptococcus pneumoniae bacteraemia leading to the diagnosis of multiple myeloma.

Authors:  Savita Shahani; Lokesh Shahani
Journal:  BMJ Case Rep       Date:  2014-09-19

6.  Management of Elderly Patients with Plasma Cell Myeloma.

Authors:  Erica L Campagnaro; Teresa E Goebel; Hillard M Lazarus
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

Review 7.  Does my patient with a serum monoclonal spike have multiple myeloma?

Authors:  Giada Bianchi; Irene M Ghobrial
Journal:  Hematol Oncol Clin North Am       Date:  2012-04       Impact factor: 3.722

8.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

9.  Diagnostic delay and complications for older adults with multiple myeloma.

Authors:  Christopher R Friese; Gregory A Abel; Lysa S Magazu; Bridget A Neville; Lisa C Richardson; Craig C Earle
Journal:  Leuk Lymphoma       Date:  2009-03

Review 10.  What is the significance of monoclonal gammopathy of undetermined significance?

Authors:  Catherine Atkin; Alex Richter; Elizabeth Sapey
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.